Research & Innovation
VCU Massey researchers have developed a promising molecule, G2.2, that targets dormant cancer stem cells to help prevent relapse. Years of research show strong preclinical results and safety across cancers, moving closer to FDA review. ...
Research & Innovation
Massey and VCU Institute of Molecular Medicine (VIMM) researchers were awarded a $1.8 million grant from the United States Department of Defense (DoD) to study the implications of using modified enhanced therapeutic versions of melanoma differentiation associated gene-7/Interleukin-24, IL-24. ...
Prevention
January is Cervical Cancer Awareness Month. We spoke with Massey gynecologic oncologist, Jaclyn Wall, M.D., to learn more about the updated guidelines for cervical cancer screening, common symptoms, treatment options and how to lower the risk of cervical cancer....
Research & Innovation
Read more to explore our newest breakthroughs from our NCI-designated Comprehensive Cancer Center and discover how our scientists are advancing cancer prevention and treatment in our latest roundup of publications from late 2025. ...
Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.
Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.
Massey is proud to partner with OncLive to provide interviews and videos from thought leaders and cutting edge articles and resources on cancer.